|
Age, mean (sd)
|
10.58 (2.34)
|
11.57 (2.08)
|
|
Males (%)
|
16 (62)
|
13 (62)
|
|
Peak expiratory flow in litres/min, mean (sd)
|
288.80 (100.80)
|
328.57 (73.02)
|
|
Number on inhaled steroids (%)
|
5 (19.2)
|
5 (23.8)
|
|
28-day asthma symptom score (0–336), median (inter-qaurtile range)
|
12.0 (6.5 to 52.5)
|
37.0 (9.0 to 69.0)
|
|
28-day rhinitis symptom score (0–252), median (inter-quartile range)
|
50.5 (19.8 to 82.5)
|
51.0 (23.5 to 84.5)
|
|
Episodes of night-time waking over 28 days, median (inter-quartile range)
|
0 (0 to 0.75)
|
0 (0 to 3.0)
|
|
28-day dose inhaled steroid mcg/month, median (inter-quartile range)
|
5600 (1450 to 11,100)
|
5400 (58 to 11,200)
|
|
28-day dose bronchodilator mcg/month, median (inter-quartile range)
|
800 (125 to 1700)
|
400 (100 to 42)
|
